How I Diagnose Anaplastic Large Cell Lymphoma

Area of Science:

• Hematology
• Oncology
• Pathology

Background:

• Anaplastic large cell lymphomas (ALCL) are CD30-positive mature T-cell neoplasms.
• ALCL encompasses four main entities: systemic ALK-positive, systemic ALK-negative, primary cutaneous ALCL, and breast implant-associated ALCL.
• These lymphomas share morphological and phenotypic similarities but exhibit diverse clinical and genetic profiles.

Observation:

• Diagnosis can be challenging due to variant histology, reliance on clinical history, and antigenic aberrancies.
• Distinguishing between ALCL subtypes requires careful evaluation of these factors.
• Potential diagnostic mimics must be recognized to ensure accurate subclassification.

Findings:

• A systematic diagnostic approach is essential for all ALCL entities.
• Correctly identifying localized forms of ALCL is crucial to prevent over-treatment.
• Awareness of diagnostic challenges and mimics improves diagnostic accuracy.

Implications:

• Improved diagnostic accuracy for ALCL leads to more appropriate patient management.
• Distinguishing localized from systemic disease prevents unnecessary aggressive therapy.
• Standardized diagnostic criteria enhance consistency in ALCL research and clinical practice.